Ranbaxy recalls Lipitor generic over dose error

India’s largest drugmaker Ranbaxy Laboratories (BSE: 500359) has recalled more than 64,000 bottles of the generic version of Pfizer’s cholesterol drug Lipitor (atorvastatin) in the USA.

Ranbaxy, majority-owned by Japan’s Daiichi Sankyo (TYO:4568), recalled the atorvastatin calcium product because a pharmacist found a 20mg tablet inside a 10mg tablet bottle. Its shares dropped as much as 3.9% to 356 rupees on Monday.

In a statement issued to Reuters, the drugmaker said: “Ranbaxy is proactively recalling the lots out of an abundance of caution, keeping the safety of its patients in mind and with the full knowledge of the US FDA.”